Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease

NCT03196427 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03196427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03196427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
July 30, 2018
Completion date
July 17, 2025
Enrollment
59 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, ulcerative colitis